{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:02:24Z","timestamp":1784599344598,"version":"3.55.0"},"reference-count":10,"publisher":"ARAN Ediciones","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.hipert.2021.05.003","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:46:48Z","timestamp":1625532408000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hipertensi\u00f3n maligna y feocromocitoma: reporte de un caso"],"prefix":"10.20960","volume":"38","author":[{"given":"R.","family":"Bury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Leon Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Casteras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Biagetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Garc\u00eda-Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cordero-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Hern\u00e1ndez Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Agraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"key":"10.1016\/j.hipert.2021.05.003_bib0055","first-page":"314","article-title":"Hypertensive crisis secondary to pheochromocytoma","volume":"30","author":"Greenleaf","year":"2017","journal-title":"Proc (Bayl Univ Med Cent)."},{"key":"10.1016\/j.hipert.2021.05.003_bib0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ecl.2011.02.002","article-title":"Hypertension in pheochromocytoma: Characteristics and treatment","volume":"40","author":"Zuber","year":"2011","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.1016\/j.hipert.2021.05.003_bib0065","first-page":"e7990","article-title":"Clinical characteristics and outcome of patients with pheochromocytoma: A single center tertiary care experience","volume":"12","author":"Sohail","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.hipert.2021.05.003_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41371-019-0267-y","article-title":"Malignant hypertension: does this still exist?","volume":"34","author":"Domek","year":"2020","journal-title":"J Hum Hypertens."},{"key":"10.1016\/j.hipert.2021.05.003_bib0075","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/01.hjh.0000249710.21146.38","article-title":"Ethnic disparities in the incidence, presentation and complications of malignant hypertension","volume":"24","author":"Van den Born B-JH","year":"2006","journal-title":"J Hypertens."},{"key":"10.1016\/j.hipert.2021.05.003_bib0080","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.hipert.2021.05.003_bib0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.hipert.2018.06.003","article-title":"Enfoque diagn\u00f3stico de feocromocitomas y paragangliomas","volume":"36","author":"G\u00f3mez","year":"2019","journal-title":"Hipertens Riesgo Vasc."},{"key":"10.1016\/j.hipert.2021.05.003_bib0090","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.hipert.2021.05.003_bib0095","first-page":"81","article-title":"Hipertensi\u00f3n arterial maligna en un adulto joven","author":"Soler","year":"2004","journal-title":"Nefrolog\u00eda (Madr)."},{"key":"10.1016\/j.hipert.2021.05.003_bib0100","first-page":"160","article-title":"Gu\u00eda ESC\/ESH 2018 sobre el diagn\u00f3stico y tratamiento de la hipertensi\u00f3n arterial","volume":"72","author":"Williams","year":"2019","journal-title":"Rev Esp Cardiol"}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183721000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183721000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:22Z","timestamp":1784596522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183721000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1889183721000490"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2021.05.003","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hipertensi\u00f3n maligna y feocromocitoma: reporte de un caso","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2021.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEH-LELHA.","name":"copyright","label":"Copyright"}]}}